Hi GG,
Specific question/s for the AGM:-
"Cavatak has continually delivered excellent results and a superb safety profile either as a monotherapy or in combination.
Pharmaceutical Companies will no doubt be totally aware of the clinical results.
Has interest been shown?... if so, by whom?... to what extent?
Thank you GG.... I look forward to reading your experience.
- Forums
- ASX - By Stock
- VLA
- Ann: New Data at SITC Meeting. Further Studies Announced
Ann: New Data at SITC Meeting. Further Studies Announced, page-86
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)